Projected cost-savings with herpes simplex virus screening in pregnancy: Towards a new screening paradigm

Sexually Transmitted Infections

Volumn 87, Issue 2, 2011, Pages 141-148

  Tuite, Ashleigh R ^a   McCabe, Caitlin J ^b   Ku, Jennifer ^c   Fisman, David N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH ECONOMICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFANT; NONHUMAN; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SEROLOGY; VIRUS TRANSMISSION;

BAYES THEOREM; COST SAVINGS; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS; QUALITY-ADJUSTED LIFE YEARS; SEXUAL PARTNERS;

EID: 79952079737     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.045559     Document Type: Article

References (30)

1. Kimberlin DW, Whitley RJ. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis 2005;16:7-16. (Pubitemid 40430824)
2. Gardella C, Handsfield HH, Whitley R. Neonatal herpes-the forgotten perinatal infection. Sex Transm Dis 2008;35:22-4. (Pubitemid 351619348)
3. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission tates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
4. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20. (Pubitemid 38032179)
5. Read JS, Cannon MJ, Stanberry LR, et al. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008;38:274-97.
6. Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003;102:753-60. (Pubitemid 37206411)
7. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-16.
8. Wald A, Krantz E, Selke S, et al. Knowledge of partners genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006;194:42-52.
9. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007;109:1489-98.
10. Turner KM, Garnett GP. The impact of the phase of an epidemic of sexually transmitted infection on the evolution of the organism. Sex Transm Infect 2002;78:i20-30.
11. Fisman DN, Hook EW III, Goldie SJ. Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex Transm Infect 2003;79:45-52. (Pubitemid 36237827)
12. Gardella C, Brown Z, Wald A, et al. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol 2005;193:1891-9. (Pubitemid 41737611)
13. Ashley RL, Wu L, Pickering JW, et al. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol 1998;36:294-5. (Pubitemid 28047483)
14. Gold M, Patrick D, Torrance G, et al. Identifying and valuing outcomes. In: Gold M, Seiga J, Russell L, Weinstein M, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:86-123.
15. Schackman BR, Oneda K, Goldie SJ. The cost-effectiveness of elective cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS 2004;18:1827-34. (Pubitemid 39179635)
16. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry 1994;31:188-205. (Pubitemid 24226070)
17. Economic costs of birth defects and cerebral palsyeUnited States, 1992. MMWR Morb Mortal Wkly Rep 1995;44:694-9. http://www.cdc.gov/mmwr/preview/ mmwrhtml/00038946.htm (accessed 12 Nov 2010).
18. Arias E, Rostron BL, Tejada-Vera BS, et al. United States life tables, 2005. Natl Vital Stat Rep 2010;58:8.
19. Gold MR, Franks P, McCoy KI, et al. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36:778-92. (Pubitemid 128454315)
20. Lahat E, Barr J, Barkai G, et al. Long term neurological outcome of herpes encephalitis. Arch Dis Child 1999;80:69-71. (Pubitemid 29142529)
21. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:450-4.
22. Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996;34:702-22. (Pubitemid 126433265)
23. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8. (Pubitemid 26337709)
24. Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004;191:2074-84.
25. Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies. Am J Obstet Gynecol 2005;192:483-8. (Pubitemid 40214984)
26. Barnabas RV, Carabin H, Garnett GP. The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Transm Infect 2002;78:425-9.
27. Tran T, Druce JD, Catton MC, et al. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm Infect 2004;80:277-9.
28. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8. (Pubitemid 29513459)
29. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009;361:1376-85.
30. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006;117:1955-62. (Pubitemid 46071239)